Reuters logo
BRIEF-Intellia Therapeutics Q3 loss per share $‍0.44​
2017年10月31日 / 下午1点16分 / 24 天前

BRIEF-Intellia Therapeutics Q3 loss per share $‍0.44​

Oct 31 (Reuters) - Intellia Therapeutics Inc:

* Intellia therapeutics announces third quarter 2017 financial results

* Q3 collaboration revenue $7.3 million versus $4.9 million

* Q3 revenue view $5.9 million -- Thomson Reuters I/B/E/S

* Says ‍well-tolerated safety profile observed for CRISPR/Cas9

* Qtrly loss per share $‍0.44​

* Q3 earnings per share view $-0.50 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below